136 related articles for article (PubMed ID: 2930592)
1. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
[TBL] [Abstract][Full Text] [Related]
2. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
[TBL] [Abstract][Full Text] [Related]
3. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
[TBL] [Abstract][Full Text] [Related]
4. The reduction of anti-tumour diaziridinyl benzoquinones.
Butler J; Hoey BM; Lea JS
Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
[TBL] [Abstract][Full Text] [Related]
5. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
King CL; Wong SK; Loo TL
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
[TBL] [Abstract][Full Text] [Related]
6. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
[TBL] [Abstract][Full Text] [Related]
7. DNA alkylation and formation of DNA interstrand cross-links by potential antitumour 2,5-bis(1-aziridinyl)-1,4-benzoquinones.
Lusthof KJ; De Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
Chem Biol Interact; 1989; 70(3-4):249-62. PubMed ID: 2663197
[TBL] [Abstract][Full Text] [Related]
8. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
[TBL] [Abstract][Full Text] [Related]
9. Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones.
Butler J; Dzielendziak A; Lea JS; Ward TH; Hoey BM
Free Radic Res Commun; 1990; 8(4-6):231-9. PubMed ID: 2162311
[TBL] [Abstract][Full Text] [Related]
10. Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells.
Ward TH; Butler J; Shahbakhti H; Richards JT
Biochem Pharmacol; 1997 Apr; 53(8):1115-21. PubMed ID: 9175716
[TBL] [Abstract][Full Text] [Related]
11. Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.
Bosanquet AG; McLoughlin SB
Invest New Drugs; 1985; 3(1):43-50. PubMed ID: 3838738
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding studies on the 14C-labeled antitumor compound 2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone radical in binding to DNA, and binding to proteins and bacterial macromolecules in situ.
Lusthof KJ; De Mol NJ; Janssen LH; Egberink RJ; Verboom W; Reinhoudt DN
Chem Biol Interact; 1990; 76(2):193-209. PubMed ID: 1699678
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
Szmigiero L; Kohn KW
Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
[TBL] [Abstract][Full Text] [Related]
14. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
Gutierrez PL
Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
[TBL] [Abstract][Full Text] [Related]
16. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.
Qiu X; Forman HJ; Schönthal AH; Cadenas E
J Biol Chem; 1996 Dec; 271(50):31915-21. PubMed ID: 8943236
[TBL] [Abstract][Full Text] [Related]
17. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
Szmigiero L; Erickson LC; Ewig RA; Kohn KW
Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZG, NSC 224070) during a phase I clinical trial.
Betteridge RF; Bosanquet AG; Gilby ED
Eur J Cancer; 1990 Feb; 26(2):107-12. PubMed ID: 2138904
[TBL] [Abstract][Full Text] [Related]
20. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
Roberts JJ; Friedlos F; Knox RJ
Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
